Cargando…
Comparison of the pharmacokinetic properties of vancomycin, linezolid, tigecyclin, and daptomycin
The rapid antibiotic resistance development has created a major demand for new antimicrobial agents that can combat resistant strains such as methicillin-resistant S. aureus (MRSA). Until a short time ago, the glycopeptide vancomycin was the only therapeutic choice in this situation. However, in rec...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352102/ https://www.ncbi.nlm.nih.gov/pubmed/21163728 http://dx.doi.org/10.1186/2047-783X-15-12-533 |